Literature DB >> 25727356

Computational psychological study of the Brief Scale for Psychiatric Problems in Orthopaedic Patients (BS-POP) for patients with chronic low back pain: verification of responsiveness.

Katshuhiro Yoshida1, Miho Sekiguchi, Koji Otani, Hirobumi Mashiko, Harumi Shioda, Takafumi Wakita, Shin-ichi Niwa, Shin-ichi Kikuchi, Shin-ichi Konno.   

Abstract

BACKGROUND: We developed the Brief Scale for Psychiatric Problems in Orthopaedic Patients (BS-POP, physician and patient versions) and have previously shown that the BS-POP is reliable and has construct validity, criterion validity, and reproducibility. The present study aimed to proactively verify the responsiveness of the BS-POP with regard to chronic low back pain (LBP) patients.
METHODS: The study subjects included 193 chronic LBP patients (81 males, 112 females; mean age 62 years) who had suffered from persistent LBP for ≥3 months. During the first test (before the treatment), the BS-POP, the Minnesota Multiphasic Personality Inventory (MMPI), the Profile of Mood States (POMS), the 36-item Short-form Health Survey version 2 (SF-36 v2), and the Roland-Morris Disability Questionnaire (RDQ) were conducted. The BS-POP, POMS, SF-36 v2, and RDQ for the third test were conducted (4-6 weeks after treatment) on all patients who had participated in the first test to determine the responsiveness of the BS-POP. The responsiveness of the BS-POP was investigated statistically.
RESULTS: The total crude BS-POP scores were significantly lower for both physician and patient versions in the third test than in the first test. Moreover, the crude RDQ scores and SF-36 v2 items, physical functioning (PF), bodily pain (BP), MH, VT, and GH, and POMS items, tension-anxiety (T-A), D, F, and confusion (C) improved significantly, confirming responsiveness to treatment. DISCUSSION: The present findings indicate that the BS-POP possesses sufficient responsiveness from a computational psychology perspective. The BS-POP constitutes a tool enabling orthopaedists to easily identify psychiatric problems in orthopaedic patients.

Entities:  

Mesh:

Year:  2015        PMID: 25727356     DOI: 10.1007/s00776-015-0694-8

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  5 in total

1.  Suppressed descending pain modulatory and enhanced sensorimotor networks in patients with chronic low back pain.

Authors:  Tianjiao Li; Shuo Zhang; Jiro Kurata
Journal:  J Anesth       Date:  2018-09-27       Impact factor: 2.078

2.  Increased Prevalence of Concomitant Psychiatric Diagnoses Among Patients Undergoing Hip Arthroscopic Surgery.

Authors:  Kag C Iglinski-Benjamin; Michelle Xiao; Marc R Safran; Geoffrey D Abrams
Journal:  Orthop J Sports Med       Date:  2019-01-25

3.  Comparison of the Effectiveness of Pharmacological Treatments for Patients with Chronic Low Back Pain: A Nationwide, Multicenter Study in Japan.

Authors:  Gen Inoue; Takashi Kaito; Yukihiro Matsuyama; Toshihiko Yamashita; Mamoru Kawakami; Kazuhisa Takahashi; Munehito Yoshida; Shiro Imagama; Seiji Ohtori; Toshihiko Taguchi; Hirotaka Haro; Hiroshi Taneichi; Masashi Yamazaki; Kotaro Nishida; Hiroshi Yamada; Daijiro Kabata; Ayumi Shintani; Motoki Iwasaki; Manabu Ito; Naohisa Miyakoshi; Hideki Murakami; Kazuo Yonenobu; Tomoyuki Takura; Joji Mochida
Journal:  Spine Surg Relat Res       Date:  2020-11-20

4.  Usefulness of the Brief Scale for Psychiatric Problems in Orthopaedic Patients (BS-POP) for Predicting Poor Outcomes in Patients Undergoing Lumbar Decompression Surgery.

Authors:  Kazuyuki Watanabe; Koji Otani; Takuya Nikaido; Kinshi Kato; Hiroshi Kobayashi; Junichi Handa; Shoji Yabuki; Shin-Ichi Kikuchi; Shin-Ichi Konno
Journal:  Pain Res Manag       Date:  2021-12-21       Impact factor: 3.037

5.  Platelet-Rich Plasma Releasate versus Corticosteroid for the Treatment of Discogenic Low Back Pain: A Double-Blind Randomized Controlled Trial.

Authors:  Koji Akeda; Kohshi Ohishi; Norihiko Takegami; Takao Sudo; Junichi Yamada; Tatsuhiko Fujiwara; Rui Niimi; Takeshi Matsumoto; Yuki Nishimura; Toru Ogura; Satoshi Tamaru; Akihiro Sudo
Journal:  J Clin Med       Date:  2022-01-07       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.